secwatch.observer — SEC 8-K summary
======================================

Issuer:     DEXCOM INC (DXCM)
CIK:        0001093557
Form:       8-K
Filed at:   2022-08-05T23:59:59+00:00
Accession:  0001093557-22-000151
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

DexCom enters $700M accelerated share repurchase agreement with JPMorgan
------------------------------------------------------------------------

- Initial payment of $700M made to JPMorgan on August 1, 2022.
- Initial delivery of ~3.0 million shares of common stock received on August 3, 2022.
- Final settlement expected in Q3 2022; based on volume-weighted average price less discount.
- Repurchase executed under existing $700M program with expiration by June 30, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1093557/000109355722000151/0001093557-22-000151-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1093557/000109355722000151/dxcm-20220801.htm
  HTML page:      https://secwatch.observer/filing/0001093557-22-000151

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer